BCL6B and gastric neoplasm: This study, along with another complementary reports [44, 45] confirmed that a specific panel of candidate genes (BCL6B, GDF1, FBP1, BNIP3, CDX1, CHFR, MGMT, MLH1, etc.)are aberrantly activated or silenced by methylation in stomach tumours.